anti-BCL2L10 (BCL2L10) Antikörper

Auf finden Sie aktuell 61 BCL2-Like 10 (Apoptosis Facilitator) (BCL2L10) Antikörper von 18 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen BCL2L10 Proteine (6) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 71 BCL2L10 Produkte verfügbar.
AA420380, AU023065, BCL-B, Boo, C85687, Diva
Alle Antikörper anzeigen Gen GeneID UniProt
BCL2L10 12049 Q9Z0F3
BCL2L10 10017 Q9HD36
BCL2L10 114552 Q99M66

Meistgesuchte Reaktivitäten zu anti-BCL2L10 (BCL2L10) Antikörper

anti-Mouse (Murine) BCL2L10 Antikörper:

anti-Human BCL2L10 Antikörper:

anti-Rat (Rattus) BCL2L10 Antikörper:

Alle verfügbaren anti-BCL2L10 Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Weitere Antikörper gegen BCL2L10 Interaktionspartner

Mouse (Murine) BCL2-Like 10 (Apoptosis Facilitator) (BCL2L10) Interaktionspartner

  1. role for Bcl-B in B cell proliferation and plasmocyte differentiation through its ability to impair B cell death and drive multiple myeloma progression.

  2. Bcl2l10, Tpx2 (zeige DAZL Antikörper), and Aurka (zeige AURKA Antikörper) co-localized on the meiotic spindles, and Bcl2l10 was present in the same complex with Tpx2 (zeige DAZL Antikörper).

  3. Protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 (zeige BCL2 Antikörper) members.

  4. analysis of a novel interaction between Bcl-2 (zeige BCL2 Antikörper) members Diva and Harakiri (zeige HRK Antikörper)

  5. Structure and sequence alignment of mouse pro-survival Bcl-2 (zeige BCL2 Antikörper) family members reveals Boo/Diva as a divergent Bcl-2 (zeige BCL2 Antikörper) protein.

  6. The role of Bcl2l10 is strongly associated with oocyte maturation, especially at the MI-MII transition.

  7. BCL2L10 is a novel and prime candidate related to oocyte maturation, fertility, and embryo developmental competence

Human BCL2-Like 10 (Apoptosis Facilitator) (BCL2L10) Interaktionspartner

  1. we describe the identification of a structural genetic variant segregating with affective psychosis in a family with multiple members suffering from bipolar I disorder. Using whole-genome sequencing, we delineated the translocation breakpoints as corresponding intragenic events disrupting BCL2L10 and PNLDC1. These data warrant further consideration for BCL2L10 and PNLDC1 as novel candidates for affective psychosis.

  2. Results found that BCL2L10 was down-regulated in human hepatocellular carcinoma (HCC (zeige FAM126A Antikörper)) tissues; its overexpression suppresses cell growth and migration of HCC (zeige FAM126A Antikörper) cell lines. These results suggested that BCL2L10 functions as a tumor-suppressor in HCC (zeige FAM126A Antikörper).

  3. BCLB expression was a starvation stress sensor inducing apoptosis and autophagy simultaneously in HCC (zeige FAM126A Antikörper) cells through the adenosine monophosphate-activated protein kinase AMPK (zeige GRK4 Antikörper)-mTOR (zeige FRAP1 Antikörper) signaling cascade.

  4. Identification of a variant in the BCL2L10 gene as a protective factor for the development of therapy-related myeloid neoplasms and de novo myelodysplastic syndrome.

  5. polyubiquitination and proteasomal turnover dictate the expression level and anti-apoptotic capacity of Bcl-B

  6. Data suggest that BCL2L10 is localized predominantly to mitochondria in high-quality preimplantation embryos/blastocysts; in contrast, abnormal embryos/blastocysts exhibit extra-mitochondrial localization (cytoplasm/cell nucleus) of BCL2L10.

  7. Bcl-B in complex with the BH3 motif of Bim (zeige BCL2L11 Antikörper) protected cells from Bax (zeige BAX Antikörper)-dependent apoptotic pathways.

  8. Bcl-B interacts with the BH3 domain of BECN1 (zeige BECN1 Antikörper) and Bcl-B overexpression reduces autophagy triggered by a variety of pro-autophagic stimuli.

  9. Ubqln stabilizes BCLb protein, while also promoting monoubiquitination on multiple lysine residues and relocation to the cytosol.

  10. BCL2L10 methylation is associated with myelodysplastic syndromes.

BCL2L10 Antigen-Profil

Beschreibung des Gens

The protein encoded by this gene belongs to the BCL-2 protein family. BCL-2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. The protein encoded by this gene contains conserved BH4, BH1 and BH2 domains. This protein can interact with other members of BCL-2 protein family including BCL2, BCL2L1/BCL-X(L), and BAX. Overexpression of this gene has been shown to suppress cell apoptosis possibly through the prevention of cytochrome C release from the mitochondria, and thus activating caspase-3 activation. The mouse counterpart of this protein is found to interact with Apaf1 and forms a protein complex with Caspase 9, which suggests the involvement of this protein in APAF1 and CASPASE 9 related apoptotic pathway.

Alternative names and synonyms associated with BCL2L10

  • Bcl2-like 10 (Bcl2l10) Antikörper
  • BCL2-like 10 (apoptosis facilitator) (BCL2L10) Antikörper
  • BCL2-like 10 (apoptosis facilitator) (Bcl2l10) Antikörper
  • AA420380 Antikörper
  • AU023065 Antikörper
  • BCL-B Antikörper
  • Boo Antikörper
  • C85687 Antikörper
  • Diva Antikörper

Bezeichner auf Proteinebene für BCL2L10

anti-apoptotic protein Boo , apoptosis regulator Bcl-B , bcl-2 homolog Diva , bcl-2-like protein 10 , bcl2-L-10 , anti-apoptotic protein NrH

12049 Mus musculus
10017 Homo sapiens
523056 Bos taurus
114552 Rattus norvegicus
Ausgewählte Anbieter für anti-BCL2L10 (BCL2L10) Antikörper
Haben Sie etwas anderes gesucht?